BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33685300)

  • 21. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.
    Quade BJ; Pinto AP; Howard DR; Peters WA; Crum CP
    Am J Pathol; 1999 Mar; 154(3):945-50. PubMed ID: 10079273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
    Commandeur AE; Styer AK; Teixeira JM
    Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells.
    de Almeida BC; Garcia N; Maffazioli G; dos Anjos LG; Baracat EC; Carvalho KC
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
    Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
    Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity.
    de Graaff MA; Cleton-Jansen AM; Szuhai K; Bovée JV
    Hum Pathol; 2013 Aug; 44(8):1597-604. PubMed ID: 23517922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization.
    Packenham JP; du Manoir S; Schrock E; Risinger JI; Dixon D; Denz DN; Evans JA; Berchuck A; Barrett JC; Devereux TR; Ried T
    Mol Carcinog; 1997 Aug; 19(4):273-9. PubMed ID: 9290705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment.
    An Y; Wang S; Li S; Zhang L; Wang D; Wang H; Zhu S; Zhu W; Li Y; Chen W; Ji S; Guo X
    BMC Cancer; 2017 Sep; 17(1):639. PubMed ID: 28893210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Functional Role and Regulatory Mechanism of FTO m
    Yang Q; Al-Hendy A
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
    Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
    Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung metastases and subsequent malignant transformation of a fumarate hydratase -deficient uterine leiomyoma.
    Ahvenainen T; Khamaiseh S; Alkodsi A; Mehine M; Nevala R; Äyräväinen A; Bützow R; Vahteristo P
    Exp Mol Pathol; 2022 Jun; 126():104760. PubMed ID: 35367216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated mutational landscape analysis of uterine leiomyosarcomas.
    Choi J; Manzano A; Dong W; Bellone S; Bonazzoli E; Zammataro L; Yao X; Deshpande A; Zaidi S; Guglielmi A; Gnutti B; Nagarkatti N; Tymon-Rosario JR; Harold J; Mauricio D; Zeybek B; Menderes G; Altwerger G; Jeong K; Zhao S; Buza N; Hui P; Ravaggi A; Bignotti E; Romani C; Todeschini P; Zanotti L; Odicino F; Pecorelli S; Ardighieri L; Bilguvar K; Quick CM; Silasi DA; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Imielinski M; Schwartz PE; Alexandrov LB; Lifton RP; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2021 Apr; 118(15):. PubMed ID: 33876771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features.
    Christacos NC; Quade BJ; Dal Cin P; Morton CC
    Genes Chromosomes Cancer; 2006 Mar; 45(3):304-12. PubMed ID: 16320247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of key genes and pathways in uterine leiomyosarcoma through bioinformatics analysis.
    Zang Y; Gu L; Zhang Y; Wang Y; Xue F
    Oncol Lett; 2018 Jun; 15(6):9361-9368. PubMed ID: 29844831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
    Schwetye KE; Pfeifer JD; Duncavage EJ
    Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uterine leiomyosarcomas with osteoclast-like giant cells associated with high expression of RUNX2 and RANKL.
    Terasaki M; Terasaki Y; Wakamatsu K; Kuwahara N; Yoneyama K; Kawase R; Kurose K; Toda E; Endo Y; Kunugi S; Kajimoto Y; Shimizu A
    Virchows Arch; 2021 May; 478(5):893-904. PubMed ID: 33404854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
    Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
    Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas.
    Zavadil J; Ye H; Liu Z; Wu J; Lee P; Hernando E; Soteropoulos P; Toruner GA; Wei JJ
    PLoS One; 2010 Aug; 5(8):e12362. PubMed ID: 20808773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrative Genomic and Transcriptomic Profiling Reveals a Differential Molecular Signature in Uterine Leiomyoma versus Leiomyosarcoma.
    Machado-Lopez A; Alonso R; Lago V; Jimenez-Almazan J; Garcia M; Monleon J; Lopez S; Barcelo F; Torroba A; Ortiz S; Domingo S; Simon C; Mas A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gamma Secretase Inhibitors as Potential Therapeutic Targets for Notch Signaling in Uterine Leiomyosarcoma.
    Abedin Y; Gabrilovich S; Alpert E; Rego E; Begum S; Zhao Q; Heller D; Einstein MH; Douglas NC
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
    Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
    Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.